Christopher P. Gordon

2.9k total citations
74 papers, 2.4k citations indexed

About

Christopher P. Gordon is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Christopher P. Gordon has authored 74 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Organic Chemistry, 31 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Christopher P. Gordon's work include Metal complexes synthesis and properties (17 papers), Ferrocene Chemistry and Applications (13 papers) and Beetle Biology and Toxicology Studies (9 papers). Christopher P. Gordon is often cited by papers focused on Metal complexes synthesis and properties (17 papers), Ferrocene Chemistry and Applications (13 papers) and Beetle Biology and Toxicology Studies (9 papers). Christopher P. Gordon collaborates with scholars based in Australia, United States and France. Christopher P. Gordon's co-authors include Adam McCluskey, Paul A. Keller, Jennette A. Sakoff, Janice R. Aldrich‐Wright, Jayne Gilbert, Paul Williams, Weng C. Chan, Phillip J. Robinson, J. Schreiber and T. Seeger and has published in prestigious journals such as Chemical Communications, Coordination Chemistry Reviews and Carbon.

In The Last Decade

Christopher P. Gordon

72 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher P. Gordon Australia 26 893 702 417 356 332 74 2.4k
Nathan Cowieson Australia 29 1.8k 2.0× 410 0.6× 712 1.7× 126 0.4× 251 0.8× 80 3.6k
Michael E. Wright United States 30 1.6k 1.8× 865 1.2× 254 0.6× 291 0.8× 348 1.0× 125 3.9k
Uwe Linne Germany 44 3.8k 4.2× 577 0.8× 447 1.1× 499 1.4× 252 0.8× 126 5.9k
Gary W. Ashley United States 33 2.3k 2.6× 837 1.2× 326 0.8× 351 1.0× 338 1.0× 93 3.9k
Pierpaolo Ceci Italy 29 1.6k 1.8× 237 0.3× 572 1.4× 384 1.1× 213 0.6× 52 3.3k
Michael D. Best United States 29 2.4k 2.7× 1.5k 2.2× 497 1.2× 484 1.4× 217 0.7× 100 4.0k
Caixia Wang China 27 818 0.9× 178 0.3× 481 1.2× 545 1.5× 151 0.5× 149 2.7k
Hervé Hillaireau France 28 1.7k 1.9× 218 0.3× 440 1.1× 866 2.4× 219 0.7× 50 3.5k

Countries citing papers authored by Christopher P. Gordon

Since Specialization
Citations

This map shows the geographic impact of Christopher P. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Gordon more than expected).

Fields of papers citing papers by Christopher P. Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Gordon. The network helps show where Christopher P. Gordon may publish in the future.

Co-authorship network of co-authors of Christopher P. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Gordon. A scholar is included among the top collaborators of Christopher P. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Gordon. Christopher P. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakoff, Jennette A., Mark J. Robertson, Kelly A. Young, et al.. (2025). Dynole‐Based Dynamin Inhibitors as Novel Cytotoxic Agents. ChemistrySelect. 10(5).
2.
Gilbert, Jayne, et al.. (2024). Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity. International Journal of Molecular Sciences. 25(4). 2181–2181. 5 indexed citations
3.
Sakoff, Jennette A., et al.. (2023). Synthesis and Characterisation of Fluorescent Novel Pt(II) Cyclometallated Complexes with Anticancer Activity. International Journal of Molecular Sciences. 24(9). 8049–8049. 4 indexed citations
4.
Sakoff, Jennette A., et al.. (2023). Synthesis and Characterisation of Platinum(II) Diaminocyclohexane Complexes with Pyridine Derivatives as Anticancer Agents. International Journal of Molecular Sciences. 24(24). 17150–17150. 4 indexed citations
5.
Sakoff, Jennette A., et al.. (2022). Novel Planar Pt(II) Cyclometallated Cytotoxic Complexes with G-Quadruplex Stabilisation and Luminescent Properties. International Journal of Molecular Sciences. 23(18). 10469–10469. 10 indexed citations
6.
Gilbert, Jayne, et al.. (2022). Potent Chlorambucil-Platinum(IV) Prodrugs. International Journal of Molecular Sciences. 23(18). 10471–10471. 16 indexed citations
7.
Sakoff, Jennette A., et al.. (2022). Potent Platinum(IV) Prodrugs That Incorporate a Biotin Moiety to Selectively Target Cancer Cells. Pharmaceutics. 14(12). 2780–2780. 14 indexed citations
8.
Sakoff, Jennette A., et al.. (2022). Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity. Pharmaceutics. 14(4). 787–787. 21 indexed citations
9.
10.
11.
Harman, David G., et al.. (2019). A continuous flow protocol to generate, regenerate, load, and recycle chlorotrityl functionalised resins. Reaction Chemistry & Engineering. 4(7). 1309–1317. 8 indexed citations
12.
Harman, David G., et al.. (2018). An optimised approach for continuous-flow solid-phase peptide synthesis utilising a rudimentary flow reactor. Reaction Chemistry & Engineering. 3(6). 875–882. 19 indexed citations
13.
McLaughlin, Eileen A., Christopher P. Gordon, Ilana R. Bernstein, et al.. (2017). Small molecule Hedgehog pathway antagonists. Organic & Biomolecular Chemistry. 15(14). 3046–3059. 3 indexed citations
14.
Cossar, Peter J., Mohammed K. Abdel‐Hamid, Cong Ma, et al.. (2017). Small-Molecule Inhibitors of the NusB–NusE Protein–Protein Interaction with Antibiotic Activity. ACS Omega. 2(7). 3839–3857. 12 indexed citations
15.
Chircop, Megan, Swetha Perera, Anna Mariana, et al.. (2011). Inhibition of Dynamin by Dynole 34-2 Induces Cell Death following Cytokinesis Failure in Cancer Cells. Molecular Cancer Therapeutics. 10(9). 1553–1562. 47 indexed citations
16.
Robertson, Mark J., Christopher P. Gordon, Jayne Gilbert, Adam McCluskey, & Jennette A. Sakoff. (2011). Norcantharimide analogues possessing terminal phosphate esters and their anti-cancer activity. Bioorganic & Medicinal Chemistry. 19(18). 5734–5741. 24 indexed citations
17.
Campbell, Bronwyn E., Christopher P. Gordon, Jennette A. Sakoff, et al.. (2011). Norcantharidin analogues with nematocidal activity in Haemonchus contortus. Bioorganic & Medicinal Chemistry Letters. 21(11). 3277–3281. 32 indexed citations
18.
Joshi, Sanket, Swetha Perera, Jayne Gilbert, et al.. (2010). The Dynamin Inhibitors MiTMAB and OcTMAB Induce Cytokinesis Failure and Inhibit Cell Proliferation in Human Cancer Cells. Molecular Cancer Therapeutics. 9(7). 1995–2006. 63 indexed citations
19.
Hill, Timothy A., Anna Mariana, Christopher P. Gordon, et al.. (2010). Iminochromene Inhibitors of Dynamins I and II GTPase Activity and Endocytosis. Journal of Medicinal Chemistry. 53(10). 4094–4102. 53 indexed citations
20.
Gordon, Christopher P., Renate Griffith, & Paul A. Keller. (2007). Control of HIV Through the Inhibition of HIV-1 Integrase: A Medicinal Chemistry Perspective. Medicinal Chemistry. 3(2). 199–220. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathan Cowieson Breakdown of academic impact, for papers by Michael E. Wright Breakdown of academic impact, for papers by Uwe Linne Breakdown of academic impact, for papers by Gary W. Ashley Breakdown of academic impact, for papers by Pierpaolo Ceci Breakdown of academic impact, for papers by Michael D. Best Breakdown of academic impact, for papers by Caixia Wang Breakdown of academic impact, for papers by Hervé Hillaireau
Rankless by CCL
2026